{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T06:27:56Z","timestamp":1794378476976,"version":"4.9.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Mitochondrial Innovation Initiative"},{"name":"MitoCanada Foundation"},{"name":"Thomas Zachos Chair"},{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Mitochondrial disease has been linked to mental health disorder in clinical cohorts and post-mortem studies. However, a lack of population-level studies examining the relationship between mitochondrial disease and mental health has resulted in an evidence gap and creates a challenge for identifying and addressing care needs for the mitochondrial disease population. Using multiple linked population health databases in a single-payer health system that covers the full population, this study aimed to investigate the prevalence of mood disorders and other mental health conditions in patients with mitochondrial disease and to examine the joint impact of mitochondrial disease and mental health conditions on healthcare use and health system costs. To contextualize these findings, a clinical comparator cohort of multiple sclerosis (MS) patients was analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Overall, co-prevalent mental health conditions are common in the mitochondrial population. Double the proportion of patients in the mitochondrial disease cohort had a co-prevalent mental health illness as compared to the MS population (18% vs 9%). Healthcare utilization was highest among patients with co-prevalent mitochondrial disease and mental illness, with 49% hospitalized within 1\u00a0year prior to cohort entry (compared to 12% of MS patients with no mental health condition). Costs were likewise highest among mitochondrial disease patients with mental health conditions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study presents the first comprehensive, population-wide cohort study of mitochondrial disease and co-prevalent mental health conditions. Our findings demonstrate a high burden of mental health conditions among mitochondrial disease patients, with high associated health care needs. We also find that patients with concurrent mental illness and mitochondrial disease represent a high-burden, high-cost population in a single-payer health insurance setting.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-025-03688-2","type":"journal-article","created":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T06:13:06Z","timestamp":1744611186000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A population-based cohort study of mitochondrial disease and mental health conditions in Ontario, Canada"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4867-869X","authenticated-orcid":false,"given":"Laura C.","family":"Rosella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mackenzie","family":"Hurst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmalin","family":"Buajitti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Samson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Trevor","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana C.","family":"Andreazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,14]]},"reference":[{"issue":"1","key":"3688_CR1","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s00415-015-7884-3","volume":"263","author":"YS Ng","year":"2016","unstructured":"Ng YS, Turnbull DM. Mitochondrial disease: genetics and management. J Neurol. 2016;263(1):179\u201391.","journal-title":"J Neurol"},{"issue":"2","key":"3688_CR2","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/path.4809","volume":"241","author":"CL Alston","year":"2017","unstructured":"Alston CL, Rocha MC, Lax NZ, Turnbull DM, Taylor RW. The genetics and pathology of mitochondrial disease. J Pathol. 2017;241(2):236\u201350.","journal-title":"J Pathol"},{"issue":"4","key":"3688_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0265744","volume":"17","author":"E Buajitti","year":"2022","unstructured":"Buajitti E, Rosella LC, Zabzuni E, Young LT, Andreazza AC. Prevalence and health care costs of mitochondrial disease in Ontario, Canada: a population-based cohort study. PLoS ONE. 2022;17(4): e0265744.","journal-title":"PLoS ONE"},{"issue":"5","key":"3688_CR4","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1002\/ana.24362","volume":"77","author":"GS Gorman","year":"2015","unstructured":"Gorman GS, Schaefer AM, Ng Y, Gomez N, Blakely EL, Alston CL, Feeney C, Horvath R, Yu-Wai-Man P, Chinnery PF, et al. Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease. Ann Neurol. 2015;77(5):753\u20139.","journal-title":"Ann Neurol"},{"issue":"2","key":"3688_CR5","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1002\/(SICI)1096-8628(20000403)96:2<182::AID-AJMG12>3.0.CO;2-Q","volume":"96","author":"T Kato","year":"2000","unstructured":"Kato T, Kunugi H, Nanko S, Kato N. Association of bipolar disorder with the 5178 polymorphism in mitochondrial DNA. Am J Med Genet. 2000;96(2):182\u20136.","journal-title":"Am J Med Genet"},{"issue":"1","key":"3688_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1744-9081-8-9","volume":"8","author":"G Inczedy-Farkas","year":"2012","unstructured":"Inczedy-Farkas G, Remenyi V, Gal A, Varga Z, Balla P, Udvardy-Meszaros A, Bereznai B, Molnar MJ. Psychiatric symptoms of patients with primary mitochondrial DNA disorders. Behav Brain Funct. 2012;8(1):9.","journal-title":"Behav Brain Funct"},{"issue":"9","key":"3688_CR7","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.biopsych.2017.09.018","volume":"83","author":"AC Andreazza","year":"2018","unstructured":"Andreazza AC, Duong A, Young LT. Bipolar disorder as a mitochondrial disease. Biol Psychiat. 2018;83(9):720\u20131.","journal-title":"Biol Psychiat"},{"issue":"5","key":"3688_CR8","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.3390\/jcm9051446","volume":"9","author":"M Catal\u00e1n-Garc\u00eda","year":"2020","unstructured":"Catal\u00e1n-Garc\u00eda M, Garc\u00eda-Garc\u00eda FJ, Moreno-Lozano PJ, Alcarraz-Viz\u00e1n G, Tort-Merino A, Milisenda JC, Cant\u00f3-Santos J, Barcos-Rodr\u00edguez T, Cardellach F, Llad\u00f3 A, et al. Mitochondrial dysfunction: a common hallmark underlying comorbidity between sIBM and other degenerative and age-related diseases. J Clin Med. 2020;9(5):1446.","journal-title":"J Clin Med"},{"issue":"4","key":"3688_CR9","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.ceb.2006.06.004","volume":"18","author":"H Chen","year":"2006","unstructured":"Chen H, Chan DC. Critical dependence of neurons on mitochondrial dynamics. Curr Opin Cell Biol. 2006;18(4):453\u20139.","journal-title":"Curr Opin Cell Biol"},{"issue":"3 Pt 1","key":"3688_CR10","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1034\/j.1399-5618.2000.020305.x","volume":"2","author":"T Kato","year":"2000","unstructured":"Kato T, Kato N. Mitochondrial dysfunction in bipolar disorder. Bipolar Disord. 2000;2(3 Pt 1):180\u201390.","journal-title":"Bipolar Disord"},{"issue":"3","key":"3688_CR11","first-page":"160","volume":"32","author":"LT Young","year":"2007","unstructured":"Young LT. Is bipolar disorder a mitochondrial disease? J Psychiatry Neurosci JPN. 2007;32(3):160\u20131.","journal-title":"J Psychiatry Neurosci JPN"},{"key":"3688_CR12","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1146\/annurev-clinpsy-082719-104030","volume":"16","author":"TE Daniels","year":"2020","unstructured":"Daniels TE, Olsen EM, Tyrka AR. Stress and psychiatric disorders: the role of mitochondria. Annu Rev Clin Psychol. 2020;16:165\u201386.","journal-title":"Annu Rev Clin Psychol"},{"issue":"1","key":"3688_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1176\/appi.psy.47.1.1","volume":"47","author":"O Fattal","year":"2006","unstructured":"Fattal O, Budur K, Vaughan AJ, Franco K. Review of the literature on major mental disorders in adult patients with mitochondrial diseases. Psychosomatics. 2006;47(1):1\u20137.","journal-title":"Psychosomatics"},{"key":"3688_CR14","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1007\/BF03403823","volume":"103","author":"FI Matheson","year":"2012","unstructured":"Matheson FI, Dunn JR, Smith KL, Moineddin R, Glazier RH. Development of the Canadian Marginalization Index: a new tool for the study of inequality. Can J Public Health. 2012;103:S12\u20136.","journal-title":"Can J Public Health"},{"issue":"3","key":"3688_CR15","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1503\/cmaj.150064","volume":"188","author":"WP Wodchis","year":"2016","unstructured":"Wodchis WP, Austin PC, Henry DA. A 3-year study of high-cost users of health care. CMAJ. 2016;188(3):182\u20138.","journal-title":"CMAJ"},{"issue":"2","key":"3688_CR16","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ymgme.2017.04.007","volume":"121","author":"SE McCormack","year":"2017","unstructured":"McCormack SE, Xiao R, Kilbaugh TJ, Karlsson M, Ganetzky RD, Cunningham ZZ, Goldstein A, Falk MJ, Damrauer SM. Hospitalizations for mitochondrial disease across the lifespan in the US. Mol Genet Metabol. 2017;121(2):119\u201326.","journal-title":"Mol Genet Metabol"},{"issue":"1","key":"3688_CR17","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1377\/hlthaff.2015.0278","volume":"35","author":"C de Oliveira","year":"2016","unstructured":"de Oliveira C, Cheng J, Vigod S, Rehm J, Kurdyak PJHA. Patients with high mental health costs incur over 30 percent more costs than other high-cost patients. Health Aff. 2016;35(1):36\u201343.","journal-title":"Health Aff"},{"issue":"6","key":"3688_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0218215","volume":"14","author":"RA Marrie","year":"2019","unstructured":"Marrie RA, O\u2019Mahony J, Maxwell CJ, Ling V, Yeh EA, Arnold DL, Bar-Or A, Banwell B. for the Canadian Pediatric demyelinating disease N: high rates of health care utilization in pediatric multiple sclerosis: A Canadian population-based study. PLoS ONE. 2019;14(6): e0218215.","journal-title":"PLoS ONE"},{"issue":"9","key":"3688_CR19","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1177\/1352458520963880","volume":"27","author":"RA Marrie","year":"2020","unstructured":"Marrie RA, Walld R, Bolton JM, Sareen J, Patten SB, Singer A, Lix LM, Hitchon CA, El-Gabalawy R, Katz A, et al. Effect of mood and anxiety disorders on health care utilization in multiple sclerosis. Mult Scler J. 2020;27(9):1411\u201320.","journal-title":"Mult Scler J"},{"issue":"1","key":"3688_CR20","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13023-018-0949-5","volume":"13","author":"B Cohen","year":"2018","unstructured":"Cohen B, Balcells C, Hotchkiss B, Aggarwal K, Karaa A. A retrospective analysis of health care utilization for patients with mitochondrial disease in the United States: 2008\u20132015. Orphanet J Rare Dis. 2018;13(1):210.","journal-title":"Orphanet J Rare Dis"},{"key":"3688_CR21","unstructured":"Wodchis WP, Bushmeneva K, Nikitovic M, McKillop I. Guidelines on person-level costing using administrative databases in Ontario. 2013."},{"issue":"8","key":"3688_CR22","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1177\/1352458514556303","volume":"21","author":"J Widdifield","year":"2015","unstructured":"Widdifield J, Ivers NM, Young J, Green D, Jaakkimainen L, Butt DA, O\u2019Connor P, Hollands S, Tu K. Development and validation of an administrative data algorithm to estimate the disease burden and epidemiology of multiple sclerosis in Ontario, Canada. Multiple Scler (Houndmills, Basingstoke, England). 2015;21(8):1045\u201354.","journal-title":"Multiple Scler (Houndmills, Basingstoke, England)"},{"key":"3688_CR23","unstructured":"MHASEF Research Team: Mental Health and Addictions System Performance in Ontario: A Baseline Scorecard. In. Toronto, ON: Institute for Clinical Evaluative Sciences; 2018."},{"key":"3688_CR24","unstructured":"Mental Illness Hospitalization [indicator] http:\/\/indicatorlibrary.cihi.ca\/display\/HSPIL\/Mental+Illness+Hospitalization"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03688-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03688-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03688-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T06:13:12Z","timestamp":1744611192000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03688-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,14]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3688"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03688-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3990108\/v1","asserted-by":"object"}]},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,14]]},"assertion":[{"value":"29 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the University of Toronto Health Sciences Research Ethics Board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"177"}}